{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T12:24:32Z","timestamp":1771849472301,"version":"3.50.1"},"reference-count":354,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100006143","name":"Department of Science and Technology, Government of Kerala","doi-asserted-by":"publisher","award":["DST\/NM\/NT\/2018\/105(G)"],"award-info":[{"award-number":["DST\/NM\/NT\/2018\/105(G)"]}],"id":[{"id":"10.13039\/501100006143","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012812","name":"Higher College of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012812","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:p>Severe acute respiratory syndrome coronavirus\u20102 (SARS\u2010CoV\u20102)\u2010induced COVID\u201019 is a complicated disease. Clinicians are continuously facing difficulties to treat infected patients using the principle of repurposing of drugs as no specific drugs are available to treat COVID\u201019. To minimize the severity and mortality, global vaccination is the only hope as a potential preventive measure. After a year\u2010long global research and clinical struggle, 165 vaccine candidates have been developed and some are currently still in the pipeline. A total of 28 candidate vaccines have been approved for use and the remainder are in different phases of clinical trials. In this comprehensive report, the authors aim to demonstrate, classify and provide up\u2010to\u2010date clinical trial status of all the vaccines discovered to date and specifically focus on the approved candidates. Finally, the authors specifically focused on the vaccination of different types of medically distinct populations.<\/jats:p>","DOI":"10.1111\/bcp.15552","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T03:08:41Z","timestamp":1664766521000},"page":"114-149","source":"Crossref","is-referenced-by-count":29,"title":["COVID\u201019: Clinical status of vaccine development to date"],"prefix":"10.1111","volume":"89","author":[{"given":"Sunny","family":"Kumar","sequence":"first","affiliation":[{"name":"Cancer Biology and Inflammatory Disorder Division Council of Scientific and Industrial Research\u2010Indian Institute of Chemical Biology (CSIR\u2010IICB)  Kolkata India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malini","family":"Basu","sequence":"additional","affiliation":[{"name":"Department of Microbiology Dhruba Chand Halder College  Dakshin Barasat India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pratyasha","family":"Ghosh","sequence":"additional","affiliation":[{"name":"Department of Economics, Bethune College University of Calcutta  Kolkata India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aafreen","family":"Ansari","sequence":"additional","affiliation":[{"name":"Cancer Biology and Inflammatory Disorder Division Council of Scientific and Industrial Research\u2010Indian Institute of Chemical Biology (CSIR\u2010IICB)  Kolkata India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4959-3065","authenticated-orcid":false,"given":"Mrinal K.","family":"Ghosh","sequence":"additional","affiliation":[{"name":"Cancer Biology and Inflammatory Disorder Division Council of Scientific and Industrial Research\u2010Indian Institute of Chemical Biology (CSIR\u2010IICB)  Kolkata India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,11,8]]},"reference":[{"key":"e_1_2_11_2_1","unstructured":"World Health Organization.Coronavirus disease (COVID\u201019). Accessed August 28 2021.https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/135965350701200S01.1"},{"key":"e_1_2_11_4_1","unstructured":"Johns Hopkins Coronavirus Resource Center.COVID\u201019 map. Accessed August 6 2021.https:\/\/coronavirus.jhu.edu\/map.html"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2020.567230"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/15299732.2020.1787296"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/tmi.13383"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.26633\/RPSP.2020.40"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2020.10.008"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10900-020-00958-x"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-020-00695-2"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3475"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/d41573-020-00073-5"},{"key":"e_1_2_11_14_1","unstructured":"COVID19 Vaccine Tracker.Types of vaccines. Accessed August 27 2021.https:\/\/covid19.trackvaccines.org\/types-of-vaccines\/"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2011.03.008"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc6284"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc4776"},{"key":"e_1_2_11_18_1","unstructured":"Inovio Pharmaceuticals Inc.Inovio accelerates timeline for COVID\u201019 DNA vaccine INO\u20104800. Accessed December 19 2021.https:\/\/www.prnewswire.com\/news-releases\/inovio-accelerates-timeline-for-covid-19-dna-vaccine-ino-4800-301015031.html"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2015.08.031"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.08.086"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.01.023"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.09.028"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1385\/MB:27:2:109"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.243"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.4161\/rna.22269"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(17)31665\u20103"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep44875"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1101\/2021.06.29.21259504"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-1417-3_2"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.06048\u201011"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.04.082"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12052-011-0365-y"},{"issue":"3","key":"e_1_2_11_33_1","first-page":"95","article-title":"Live attenuated influenza vaccine\u2014a review","volume":"52","author":"Gasparini R","year":"2011","journal-title":"J Prev Med Hyg"},{"key":"e_1_2_11_34_1","volume-title":"Vaccines E\u2010Book","author":"Plotkin SA","year":"2012"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2014.883285"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajps.2020.08.001"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.2174\/156652321403140819122538"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1525\u20100016(03)00168\u20100"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2014.37"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2016.1121990"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.2.633"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2016.1124762"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.188.6.1075"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1159\/000053994"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03401683"},{"issue":"1","key":"e_1_2_11_46_1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4049\/jimmunol.159.1.11","article-title":"The dominant role of bone marrow\u2010derived cells in CTL induction following plasmid DNA immunization at different sites","volume":"159","author":"Iwasaki A","year":"1997","journal-title":"J Immunol"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.184.4.1555"},{"key":"e_1_2_11_48_1","unstructured":"COVID19 Vaccine Tracker.Vaccines. Accessed August 27 2021.https:\/\/covid19.trackvaccines.org\/vaccines\/"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101020"},{"key":"e_1_2_11_50_1","unstructured":"COVID19 Vaccine Tracker.Zydus Cadila: ZyCoV\u2010D. Accessed December 19 2021.https:\/\/covid19.trackvaccines.org\/vaccines\/29\/"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/298347a0"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.07.046"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004876.pub4"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004879.pub5"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.3390\/v10120718"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00614\u201015"},{"key":"e_1_2_11_57_1","unstructured":"COVID19 Vaccine Tracker.FBRI: EpiVacCorona. Accessed December 19 2021.https:\/\/covid19.trackvaccines.org\/vaccines\/32\/"},{"key":"e_1_2_11_58_1","doi-asserted-by":"publisher","DOI":"10.15789\/2220\u20107619\u2010ASB\u20101699"},{"key":"e_1_2_11_59_1","unstructured":"COVID19 Vaccine Tracker.Sinopharm (Wuhan): Inactivated (Vero Cells). Accessed December 19 2021.https:\/\/covid19.trackvaccines.org\/vaccines\/16\/"},{"key":"e_1_2_11_60_1","unstructured":"COVID19 Vaccine Tracker.Sinovac: CoronaVac. Accessed December 19 2021.https:\/\/covid19.trackvaccines.org\/vaccines\/7\/"},{"key":"e_1_2_11_61_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.52.4.632"},{"key":"e_1_2_11_62_1","doi-asserted-by":"publisher","DOI":"10.1177\/2051013615595595"},{"key":"e_1_2_11_63_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-021-00806-7"},{"key":"e_1_2_11_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00396-0"},{"key":"e_1_2_11_65_1","doi-asserted-by":"publisher","DOI":"10.2174\/1570162053506900"},{"key":"e_1_2_11_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(92)90411-C"},{"key":"e_1_2_11_67_1","unstructured":"COVID19 Vaccine Tracker.Anhui Zhifei Longcom: ZF2001. Accessed December 19 2021.https:\/\/covid19.trackvaccines.org\/vaccines\/27\/"},{"key":"e_1_2_11_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473\u20103099(21)00127\u20104"},{"key":"e_1_2_11_69_1","unstructured":"COVID19 Vaccine Tracker.Center for Genetic Engineering and Biotechnology (CIGB): CIGB\u201066. Accessed December 19 2021.https:\/\/covid19.trackvaccines.org\/vaccines\/67\/"},{"key":"e_1_2_11_70_1","unstructured":"COVID19 Vaccine Tracker.Gamaleya: Sputnik V. Accessed December 19 2021.https:\/\/covid19.trackvaccines.org\/vaccines\/12\/"},{"key":"e_1_2_11_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(21)00191\u20104"},{"key":"e_1_2_11_72_1","article-title":"Interim report: safety and immunogenicity of an inactivated vaccine against SARS\u2010CoV\u20102 in healthy chilean adults in a phase 3 clinical trial","author":"Bueno SM","year":"2021","journal-title":"medRxiv"},{"key":"e_1_2_11_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473\u20103099(21)00319\u20104"},{"key":"e_1_2_11_74_1","unstructured":"Registro P\u00fablico Cubano de Ensayos Cl\u00ednicos.Evaluation of the safety and immunogenicity of the vaccine candidate \u201cABDALA\u201d in children and adolescents. Accessed December 19 2021.https:\/\/rpcec.sld.cu\/en\/trials\/RPCEC00000381-En"},{"key":"e_1_2_11_75_1","unstructured":"COVID19 Vaccine Tracker.Instituto Finlay de Vacunas Cuba: Soberana 02. Accessed December 19 2021.https:\/\/covid19.trackvaccines.org\/vaccines\/52\/"},{"key":"e_1_2_11_76_1","unstructured":"COVID19 Vaccine Tracker.Chumakov Center: KoviVac. Accessed December 19 2021.https:\/\/covid19.trackvaccines.org\/vaccines\/100\/"},{"key":"e_1_2_11_77_1","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2021.1971569"},{"key":"e_1_2_11_78_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01539"},{"key":"e_1_2_11_79_1","unstructured":"COVID19 Vaccine Tracker.Moderna: mRNA\u20101273. Accessed December 19 2021.https:\/\/covid19.trackvaccines.org\/vaccines\/22\/"},{"key":"e_1_2_11_80_1","unstructured":"COVID19 Vaccine Tracker.Kazakhstan RIBSP: QazVac. Accessed December 19 2021.https:\/\/covid19.trackvaccines.org\/vaccines\/30\/"},{"key":"e_1_2_11_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101078"},{"key":"e_1_2_11_82_1","unstructured":"COVID19 Vaccine Tracker.Gamaleya: Sputnik Light. Accessed December 19 2021.https:\/\/covid19.trackvaccines.org\/vaccines\/126\/"},{"key":"e_1_2_11_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100241"},{"key":"e_1_2_11_84_1","unstructured":"Takeda.A phase 1\/2 randomized observer\u2010blind placebo\u2010controlled trial to evaluate the safety and immunogenicity of TAK\u2010919 by intramuscular injection in healthy Japanese male and female adults aged 20 years and older (COVID\u201019).2021. Accessed December 16 2021.https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04677660"},{"key":"e_1_2_11_85_1","unstructured":"COVID19 Vaccine Tracker.Pfizer\/BioNTech: BNT162b2. Accessed December 19 2021.https:\/\/covid19.trackvaccines.org\/vaccines\/6\/"},{"key":"e_1_2_11_86_1","article-title":"Safety and immunogenicity of anti\u2010SARS CoV\u20102 vaccine SOBERANA 02 in homologous or heterologous scheme","author":"Toledo\u2010Romani ME","year":"2021","journal-title":"medRxiv"},{"key":"e_1_2_11_87_1","unstructured":"COVID19 Vaccine Tracker.Instituto Finlay de Vacunas Cuba: Soberana Plus. Accessed December 19 2021.https:\/\/covid19.trackvaccines.org\/vaccines\/119\/"},{"key":"e_1_2_11_88_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2101544"},{"key":"e_1_2_11_89_1","unstructured":"COVID19 Vaccine Tracker.Medigen: MVC\u2010COV1901. Accessed December 19 2021.https:\/\/covid19.trackvaccines.org\/vaccines\/24\/"},{"key":"e_1_2_11_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213\u20102600(21)00402\u20101"},{"key":"e_1_2_11_91_1","unstructured":"COVID19 Vaccine Tracker.Minhai Biotechnology Co: SARS\u2010CoV\u20102 Vaccine (Vero Cells). Accessed December 19 2021.https:\/\/covid19.trackvaccines.org\/vaccines\/47\/"},{"key":"e_1_2_11_92_1","doi-asserted-by":"publisher","DOI":"10.1101\/2021.04.07.21253850"},{"key":"e_1_2_11_93_1","doi-asserted-by":"publisher","DOI":"10.1586\/erv.09.49"},{"issue":"1","key":"e_1_2_11_94_1","first-page":"S20","article-title":"A brief history of vaccines against polio","volume":"53","author":"Vashishtha VM","year":"2016","journal-title":"Indian Pediatr"},{"key":"e_1_2_11_95_1","unstructured":"COVID19 Vaccine Tracker.Bharat Biotech: Covaxin. Accessed December 19 2021.https:\/\/covid19.trackvaccines.org\/vaccines\/9\/"},{"key":"e_1_2_11_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(21)02000\u20106"},{"key":"e_1_2_11_97_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.8565"},{"key":"e_1_2_11_98_1","unstructured":"COVID19 Vaccine Tracker.Sinopharm (Beijing): BBIBP\u2010CorV (Vero Cells). Accessed December 19 2021.https:\/\/covid19.trackvaccines.org\/vaccines\/5\/"},{"key":"e_1_2_11_99_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2119912"},{"key":"e_1_2_11_100_1","unstructured":"COVID19 Vaccine Tracker.Takeda: TAK\u2010919 (Moderna formulation). Accessed December 19 2021.https:\/\/covid19.trackvaccines.org\/vaccines\/79\/"},{"key":"e_1_2_11_101_1","unstructured":"COVID19 Vaccine Tracker.Razi Vaccine and Serum Research Institute: Razi Cov Pars. Accessed December 19 2021.https:\/\/covid19.trackvaccines.org\/vaccines\/82\/"},{"key":"e_1_2_11_102_1","unstructured":"IRCT.Phase II safety and immunogenicity of RAZI SARS\u2010CoV\u20102 recombinant Spike protein vaccine (RAZI Cov Pars) in adults aged 18\u201070 years; a randomised double blind parallel 2 arms clinical trial. Accessed December 19 2021.https:\/\/en.irct.ir\/trial\/55238"},{"key":"e_1_2_11_103_1","article-title":"Marked enhancement of neutralizing antibody and IFN\u2010\u03b3 T\u2010cell responses by GX\u201019N DNA booster in mice primed with inactivated vaccine","author":"Seo YB","year":"2021","journal-title":"bioRxiv"},{"key":"e_1_2_11_104_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01963"},{"key":"e_1_2_11_105_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3302213"},{"key":"e_1_2_11_106_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.2.2.2620"},{"key":"e_1_2_11_107_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aac7462"},{"key":"e_1_2_11_108_1","doi-asserted-by":"publisher","DOI":"10.1007\/978\u20101\u201062703\u2010260\u20105_2"},{"key":"e_1_2_11_109_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-62703-260-5_3"},{"key":"e_1_2_11_110_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.5.11.2108"},{"key":"e_1_2_11_111_1","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb724"},{"key":"e_1_2_11_112_1","first-page":"179","volume-title":"Advances in Genetics","author":"Brito LA","year":"2015"},{"key":"e_1_2_11_113_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.19.10394-10403.2003"},{"key":"e_1_2_11_114_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1209367109"},{"key":"e_1_2_11_115_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1355245"},{"key":"e_1_2_11_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.11.017"},{"key":"e_1_2_11_117_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-016-1869-7"},{"key":"e_1_2_11_118_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2000.00929.x"},{"key":"e_1_2_11_119_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-004-4255-0"},{"key":"e_1_2_11_120_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-0699"},{"key":"e_1_2_11_121_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep22509"},{"key":"e_1_2_11_122_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature23003"},{"issue":"3","key":"e_1_2_11_123_1","first-page":"262","article-title":"Gene gun delivery of mRNA in situ results in efficient transgene expression and genetic immunization","volume":"3","author":"Qiu P","year":"1996","journal-title":"Gene Ther"},{"key":"e_1_2_11_124_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-005-0042-5"},{"key":"e_1_2_11_125_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.24.15107-15113.2005"},{"key":"e_1_2_11_126_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-017-0032-6"},{"key":"e_1_2_11_127_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr695"},{"key":"e_1_2_11_128_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0703778104"},{"key":"e_1_2_11_129_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature21428"},{"key":"e_1_2_11_130_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.03.035"},{"key":"e_1_2_11_131_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2010.85"},{"key":"e_1_2_11_132_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.08.007"},{"key":"e_1_2_11_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.02.017"},{"key":"e_1_2_11_134_1","doi-asserted-by":"publisher","DOI":"10.1002\/iub.1625"},{"key":"e_1_2_11_135_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-016-0927-4"},{"key":"e_1_2_11_136_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-016-1111-6"},{"key":"e_1_2_11_137_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.05.046"},{"key":"e_1_2_11_138_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.08.006"},{"key":"e_1_2_11_139_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035389"},{"key":"e_1_2_11_140_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n3105"},{"key":"e_1_2_11_141_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01446-y"},{"key":"e_1_2_11_142_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(21)02183\u20108"},{"key":"e_1_2_11_143_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2029"},{"key":"e_1_2_11_144_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41564\u2010021\u201001053\u20100"},{"key":"e_1_2_11_145_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2119270"},{"key":"e_1_2_11_146_1","unstructured":"Ben\u2010Gurion University Research Portal.BNT162b2 mRNA Covid\u201019 vaccine in a nationwide mass vaccination setting. Reply. Accessed March 2 2022.https:\/\/cris.bgu.ac.il\/en\/publications\/bnt162b2-mrna-covid-19-vaccine-in-a-nationwide-mass-vaccination-s-2"},{"key":"e_1_2_11_147_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10787\u2010021\u201000839\u20102"},{"key":"e_1_2_11_148_1","first-page":"100134","article-title":"Real\u2010world effectiveness of the mRNA\u20101273 vaccine against COVID\u201019: interim results from a prospective observational cohort study","volume":"6","author":"Bruxvoort KJ","year":"2021","journal-title":"Lancet Reg Health\u2010Am"},{"key":"e_1_2_11_149_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.11.009"},{"key":"e_1_2_11_150_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.04.047"},{"key":"e_1_2_11_151_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26996"},{"key":"e_1_2_11_152_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473\u20103099(22)00146\u20103"},{"key":"e_1_2_11_153_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467\u2010022\u201030884\u20106"},{"key":"e_1_2_11_154_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2118946"},{"key":"e_1_2_11_155_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7027e2"},{"key":"e_1_2_11_156_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.056135"},{"key":"e_1_2_11_157_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2109730"},{"key":"e_1_2_11_158_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2021.2833"},{"key":"e_1_2_11_159_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2110475"},{"key":"e_1_2_11_160_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000755"},{"key":"e_1_2_11_161_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40119\u2010021\u201000248\u20100"},{"key":"e_1_2_11_162_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14837"},{"key":"e_1_2_11_163_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.04.006"},{"key":"e_1_2_11_164_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.13651"},{"issue":"9","key":"e_1_2_11_165_1","first-page":"e103","article-title":"Acute coronary tree thrombosis after vaccination for COVID\u201019","volume":"14","author":"Tajstra M","year":"2021","journal-title":"Cardiovasc Interv"},{"key":"e_1_2_11_166_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2021.04.018"},{"key":"e_1_2_11_167_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.121.17316"},{"key":"e_1_2_11_168_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2021.06.013"},{"key":"e_1_2_11_169_1","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000001379"},{"key":"e_1_2_11_170_1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-246580"},{"key":"e_1_2_11_171_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601877"},{"key":"e_1_2_11_172_1","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2017.14465"},{"key":"e_1_2_11_173_1","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0b013e32833d1fca"},{"key":"e_1_2_11_174_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2015.103"},{"key":"e_1_2_11_175_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.08.051"},{"key":"e_1_2_11_176_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.12.032"},{"key":"e_1_2_11_177_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4278"},{"key":"e_1_2_11_178_1","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2012.0076"},{"key":"e_1_2_11_179_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00083-06"},{"key":"e_1_2_11_180_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.08.011"},{"key":"e_1_2_11_181_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.09.106"},{"key":"e_1_2_11_182_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2009.05.003"},{"key":"e_1_2_11_183_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.10.031"},{"key":"e_1_2_11_184_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01048-13"},{"key":"e_1_2_11_185_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.06.035"},{"key":"e_1_2_11_186_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature12328"},{"key":"e_1_2_11_187_1","doi-asserted-by":"publisher","DOI":"10.3390\/v11030212"},{"key":"e_1_2_11_188_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.06.041"},{"key":"e_1_2_11_189_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112602"},{"key":"e_1_2_11_190_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/136.Supplement_3.S450"},{"key":"e_1_2_11_191_1","unstructured":"COVID19 Vaccine Tracker.Serum Institute of India: COVOVAX (Novavax formulation). Accessed December 19 2021.https:\/\/covid19.trackvaccines.org\/vaccines\/123\/"},{"key":"e_1_2_11_192_1","unstructured":"AAAS.Novavax vaccine delivers 89% efficacy against COVID\u201019 in U.K.\u2014but is less potent in South Africa. Accessed December 19 2021.https:\/\/www.science.org\/content\/article\/novavax-vaccine-delivers-89-efficacy-against-covid-19-uk-less-potent-south-africa"},{"key":"e_1_2_11_193_1","unstructured":"COVID19 Vaccine Tracker.Vaxine\/CinnaGen Co.: COVAX\u201019. Accessed December 19 2021.https:\/\/covid19.trackvaccines.org\/vaccines\/8\/"},{"key":"e_1_2_11_194_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccmp.2021.100004"},{"key":"e_1_2_11_195_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2026920"},{"key":"e_1_2_11_196_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8010139"},{"key":"e_1_2_11_197_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.11.092"},{"key":"e_1_2_11_198_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035421"},{"key":"e_1_2_11_199_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12033-012-9598-4"},{"key":"e_1_2_11_200_1","doi-asserted-by":"publisher","DOI":"10.1586\/erv.11.135"},{"key":"e_1_2_11_201_1","doi-asserted-by":"publisher","DOI":"10.1038\/2181057a0"},{"key":"e_1_2_11_202_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2006.05.020"},{"key":"e_1_2_11_203_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-017-0006-8"},{"key":"e_1_2_11_204_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2105"},{"key":"e_1_2_11_205_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00273\u201017"},{"key":"e_1_2_11_206_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2009.08.005"},{"key":"e_1_2_11_207_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbt.2017.07.010"},{"key":"e_1_2_11_208_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjp.2008.349"},{"key":"e_1_2_11_209_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2017.04.001"},{"key":"e_1_2_11_210_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00298-16"},{"key":"e_1_2_11_211_1","doi-asserted-by":"publisher","DOI":"10.2174\/1566523213666131125095046"},{"key":"e_1_2_11_212_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.01.064"},{"key":"e_1_2_11_213_1","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.10.3.476-478.2003"},{"key":"e_1_2_11_214_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11262-017-1486-3"},{"key":"e_1_2_11_215_1","doi-asserted-by":"publisher","DOI":"10.1053\/tvjl.1998.0303"},{"key":"e_1_2_11_216_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.10.4477"},{"key":"e_1_2_11_217_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01106-12"},{"key":"e_1_2_11_218_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2006.10.026"},{"key":"e_1_2_11_219_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02055-12"},{"key":"e_1_2_11_220_1","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12829"},{"key":"e_1_2_11_221_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.29594"},{"key":"e_1_2_11_222_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir850"},{"key":"e_1_2_11_223_1","doi-asserted-by":"publisher","DOI":"10.7326\/M15-0880"},{"key":"e_1_2_11_224_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1122146"},{"key":"e_1_2_11_225_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)70043-5"},{"key":"e_1_2_11_226_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-008748"},{"key":"e_1_2_11_227_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.12.042"},{"key":"e_1_2_11_228_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00266-2"},{"key":"e_1_2_11_229_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2007.10.010"},{"key":"e_1_2_11_230_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines2030624"},{"key":"e_1_2_11_231_1","unstructured":"COVID19 Vaccine Tracker.CanSino: Ad5\u2010nCoV. Accessed December 19 2021.https:\/\/covid19.trackvaccines.org\/vaccines\/2\/"},{"key":"e_1_2_11_232_1","unstructured":"COVID19 Vaccine Tracker.Janssen (Johnson & Johnson): Ad26.COV2.S. Accessed December 19 2021.https:\/\/covid19.trackvaccines.org\/vaccines\/1\/"},{"key":"e_1_2_11_233_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32661-1"},{"key":"e_1_2_11_234_1","unstructured":"Scribd.WHO 2019 NCoV Vaccines SAGE Recommendation AZD1222 2021.3 Eng|PDF|Pregnancy|Vaccines. Accessed December 19 2021.https:\/\/www.scribd.com\/document\/531662920\/WHO-2019-NCoV-Vaccines-SAGE-Recommendation-AZD1222-2021-3-Eng"},{"key":"e_1_2_11_235_1","unstructured":"COVID19 Vaccine Tracker.Oxford\/AstraZeneca: AZD1222. Accessed December 19 2021.https:\/\/covid19.trackvaccines.org\/vaccines\/4\/"},{"key":"e_1_2_11_236_1","unstructured":"COVID19 Vaccine Tracker.Serum Institute of India: Covishield (Oxford\/AstraZeneca formulation). Accessed December 19 2021.https:\/\/covid19.trackvaccines.org\/vaccines\/48\/"},{"key":"e_1_2_11_237_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2102214"},{"key":"e_1_2_11_238_1","article-title":"Effectiveness of COVID\u201019 vaccines against the Omicron (B.1.1.529) variant of concern","author":"Andrews N","year":"2021","journal-title":"medRxiv"},{"key":"e_1_2_11_239_1","doi-asserted-by":"publisher","DOI":"10.3390\/biology10080752"},{"key":"e_1_2_11_240_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.16496"},{"key":"e_1_2_11_241_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2106075"},{"key":"e_1_2_11_242_1","article-title":"Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID\u201019 vaccine safety surveillance: incidence between 2017 and 2019 and patient profiles from 20.6 million people in six European countries","author":"Burn E","year":"2021","journal-title":"medRxiv"},{"key":"e_1_2_11_243_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2021.05.001"},{"key":"e_1_2_11_244_1","volume-title":"Joint CDC and FDA Statement on Johnson & Johnson COVID\u201019 Vaccine","author":"Marks P","year":"2021"},{"key":"e_1_2_11_245_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1114"},{"key":"e_1_2_11_246_1","doi-asserted-by":"publisher","DOI":"10.31491\/APT.2021.06.059"},{"key":"e_1_2_11_247_1","doi-asserted-by":"publisher","DOI":"10.2174\/15665232113136660005"},{"key":"e_1_2_11_248_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.04.060"},{"key":"e_1_2_11_249_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.02.015"},{"key":"e_1_2_11_250_1","unstructured":"Vax Report.Understanding pre\u2010existing immunity. Accessed March 4 2022.https:\/\/www.vaxreport.org\/vax-3-2-february-2005\/801-understanding-pre-existing-immunity"},{"key":"e_1_2_11_251_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577\u2010020\u20100389\u2010z"},{"key":"e_1_2_11_252_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2004.06.014"},{"key":"e_1_2_11_253_1","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxh143"},{"key":"e_1_2_11_254_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.06.038"},{"key":"e_1_2_11_255_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41426\u2010018\u20100056\u20107"},{"key":"e_1_2_11_256_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.9.6337"},{"key":"e_1_2_11_257_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0818-9641.2004.01272.x"},{"key":"e_1_2_11_258_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2668"},{"key":"e_1_2_11_259_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4613-2613-7_8"},{"key":"e_1_2_11_260_1","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2017.1407035"},{"key":"e_1_2_11_261_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.03.078"},{"key":"e_1_2_11_262_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00479-7"},{"key":"e_1_2_11_263_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00416-2"},{"key":"e_1_2_11_264_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.07.111"},{"key":"e_1_2_11_265_1","doi-asserted-by":"publisher","DOI":"10.1086\/313951"},{"issue":"3","key":"e_1_2_11_266_1","first-page":"375","article-title":"Hepatitis virus vaccines: present status","volume":"55","author":"Krugman S","year":"1982","journal-title":"Yale J Biol Med"},{"key":"e_1_2_11_267_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000976"},{"key":"e_1_2_11_268_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102249.2012.04592.x"},{"key":"e_1_2_11_269_1","unstructured":"COVID19 Vaccine Tracker.Organization of Defensive Innovation and Research: FAKHRAVAC (MIVAC). Accessed December 19 2021.https:\/\/covid19.trackvaccines.org\/vaccines\/97\/"},{"key":"e_1_2_11_270_1","unstructured":"IRCT.Comparison of the safety efficacy and immunogenicity of Fakhravac and Sinopharm SARS\u2010CoV\u20102 vaccines in adults aged 18 and over; a phase III randomised non\u2010inferiority clinical trial. Accessed December 19 2021.https:\/\/en.irct.ir\/trial\/57980"},{"key":"e_1_2_11_271_1","unstructured":"COVID19 Vaccine Tracker.Shifa Pharmed Industrial Co: COVID\u201019 inactivated vaccine. Accessed December 19 2021.https:\/\/covid19.trackvaccines.org\/vaccines\/83\/"},{"key":"e_1_2_11_272_1","doi-asserted-by":"publisher","DOI":"10.1101\/2021.06.10.447951"},{"key":"e_1_2_11_273_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14268"},{"key":"e_1_2_11_274_1","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm\u20102021\u2010002794"},{"key":"e_1_2_11_275_1","doi-asserted-by":"publisher","DOI":"10.4103\/0974-777X.77299"},{"key":"e_1_2_11_276_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2015.03.032"},{"key":"e_1_2_11_277_1","doi-asserted-by":"publisher","DOI":"10.3390\/v6041672"},{"key":"e_1_2_11_278_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-45024-6"},{"key":"e_1_2_11_279_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01651\u201016"},{"key":"e_1_2_11_280_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00087\u201013"},{"key":"e_1_2_11_281_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00304\u201008"},{"key":"e_1_2_11_282_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1726"},{"key":"e_1_2_11_283_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-811710-1.00024-0"},{"key":"e_1_2_11_284_1","doi-asserted-by":"publisher","DOI":"10.1159\/000514225"},{"key":"e_1_2_11_285_1","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202004210"},{"key":"e_1_2_11_286_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41422\u2010022\u201000612\u20102"},{"key":"e_1_2_11_287_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.114020"},{"key":"e_1_2_11_288_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41423\u2010021\u201000669\u2010w"},{"key":"e_1_2_11_289_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41422\u2010020\u201000395\u20104"},{"key":"e_1_2_11_290_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473\u20103099(21)00200\u20100"},{"key":"e_1_2_11_291_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abi4547"},{"key":"e_1_2_11_292_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.01.022"},{"key":"e_1_2_11_293_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009383"},{"key":"e_1_2_11_294_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9090957"},{"key":"e_1_2_11_295_1","doi-asserted-by":"publisher","DOI":"10.1039\/d1cc06520c"},{"key":"e_1_2_11_296_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392\u2010020\u201000434\u2010x"},{"key":"e_1_2_11_297_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003769"},{"key":"e_1_2_11_298_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.07.087"},{"key":"e_1_2_11_299_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27063-4"},{"issue":"2","key":"e_1_2_11_300_1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4049\/jimmunol.138.2.435","article-title":"Analysis of paraprotein transport into the saliva by using anti\u2010idiotype antibodies","volume":"138","author":"Kubagawa H","year":"1987","journal-title":"J Immunol"},{"key":"e_1_2_11_301_1","article-title":"Intramuscular SARS\u2010CoV\u20102 vaccines elicit varying degrees of plasma and salivary antibody responses as compared to natural infection","author":"Nahass GR","year":"2021","journal-title":"medRxiv"},{"key":"e_1_2_11_302_1","doi-asserted-by":"publisher","DOI":"10.20411\/pai.v6i1.441"},{"key":"e_1_2_11_303_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.611337"},{"key":"e_1_2_11_304_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.07.022"},{"key":"e_1_2_11_305_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.202604"},{"key":"e_1_2_11_306_1","unstructured":"CDC.COVID\u201019 vaccines for specific groups of people. Accessed March 3 2022.https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/recommendations\/specific-groups.html"},{"key":"e_1_2_11_307_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00737-020-01086-0"},{"key":"e_1_2_11_308_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-021-01131-6"},{"key":"e_1_2_11_309_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6944e3"},{"key":"e_1_2_11_310_1","unstructured":"Prevent Child Abuse Vermont.Pregnancy during Covid\u201019. Accessed March 2 2022.https:\/\/www.pcavt.org\/parents-corner-blog\/2020\/6\/9\/pregnancy-during-covid-19?gclid=CjwKCAiAyPyQBhB6EiwAFUuakp6jW6Xc0mHI3yxQaWDDw_Zn9QT4yi2dKuoDHBcrz-vzcGRvVFvkUhoCjtUQAvD_BwE"},{"key":"e_1_2_11_311_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01490-8"},{"key":"e_1_2_11_312_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.11035"},{"key":"e_1_2_11_313_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2021.06.055"},{"key":"e_1_2_11_314_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.5782"},{"key":"e_1_2_11_315_1","unstructured":"WHO.Update on WHO Interim recommendations on COVID\u201019 vaccination of pregnant and lactating women. Accessed March 2 2022.https:\/\/www.who.int\/publications\/m\/item\/update-on-who-interim-recommendations-on-covid-19-vaccination-of-pregnant-and-lactating-women"},{"key":"e_1_2_11_316_1","unstructured":"Royal College of Obstetricians and Gynaecologists.COVID\u201019 vaccines pregnancy and breastfeeding. Accessed March 2 2022.https:\/\/www.rcog.org.uk\/en\/guidelines-research-services\/coronavirus-covid-19-pregnancy-and-womens-health\/covid-19-vaccines-and-pregnancy\/covid-19-vaccines-pregnancy-and-breastfeeding\/"},{"key":"e_1_2_11_317_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2488-1"},{"key":"e_1_2_11_318_1","article-title":"Coronavirus disease\u201019: The first 7,755 cases in the Republic of Korea","author":"COVID\u201019 National Emergency Response Center, Epidemiology Center, Epidemiology and Case Management Team, Korea Centers for Disease Control and Prevention","year":"2020","journal-title":"medRxiv"},{"key":"e_1_2_11_319_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2006100"},{"key":"e_1_2_11_320_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-0702"},{"key":"e_1_2_11_321_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedneo.2020.03.001"},{"key":"e_1_2_11_322_1","unstructured":"Istat.First results of the SARS\u2010CoV\u20102 seroprevalence survey. Accessed March 3 2022.https:\/\/www.istat.it\/it\/archivio\/246156"},{"key":"e_1_2_11_323_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eswa.2020.113970"},{"key":"e_1_2_11_324_1","unstructured":"WHO.Multisystem inflammatory syndrome in children and adolescents temporally related to COVID\u201019. Accessed March 3 2022.https:\/\/www.who.int\/news-room\/commentaries\/detail\/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19"},{"key":"e_1_2_11_325_1","unstructured":"FDA.Comirnaty and Pfizer\u2010BioNTech COVID\u201019 vaccine. Accessed March 3 2022.https:\/\/www.fda.gov\/emergency-preparedness-and-response\/coronavirus-disease-2019-covid-19\/comirnaty-and-pfizer-biontech-covid-19-vaccine#additional"},{"key":"e_1_2_11_326_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa863"},{"key":"e_1_2_11_327_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.02.024"},{"key":"e_1_2_11_328_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218946"},{"issue":"9","key":"e_1_2_11_329_1","first-page":"1163","article-title":"Anti\u2010COVID\u201019 vaccination in patients with autoimmune\u2010autoinflammatory disorders and primary\/secondary immunodeficiencies: the position of the Task Force on Behalf of the Italian Immunological Societies","volume":"9","author":"D'Amelio R","year":"2021","journal-title":"Biomedicine"},{"key":"e_1_2_11_330_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.4385"},{"key":"e_1_2_11_331_1","first-page":"21257102","article-title":"Spike\u2010antibody responses following first and second doses of ChAdOx1 and BNT162b2 vaccines by age, gender, and clinical factors\u2010a prospective community cohort study (Virus Watch)","volume":"5","author":"Shrotri M","year":"2021","journal-title":"medRxiv"},{"key":"e_1_2_11_332_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abj1031"},{"key":"e_1_2_11_333_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2021.05.004"},{"key":"e_1_2_11_334_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab345"},{"key":"e_1_2_11_335_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2021.12.044"},{"key":"e_1_2_11_336_1","unstructured":"Australasian Society of Clinical Immunology and Allergy (ASCIA).ASCIA HP Position Statement COVID\u201019 Vaccination. Accessed March 3 2022.https:\/\/www.allergy.org.au\/hp\/papers\/ascia-hp-position-statement-covid-19-vaccination"},{"key":"e_1_2_11_337_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis\u20102021\u2010220597"},{"key":"e_1_2_11_338_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468\u20101253(22)00005\u2010X"},{"key":"e_1_2_11_339_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665\u20109913(21)00393\u20103"},{"key":"e_1_2_11_340_1","doi-asserted-by":"publisher","DOI":"10.1186\/s41232\u2010021\u201000159\u20106"},{"key":"e_1_2_11_341_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2021.08.003"},{"key":"e_1_2_11_342_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2022.07.024"},{"key":"e_1_2_11_343_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.09.020"},{"key":"e_1_2_11_344_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.09.010"},{"key":"e_1_2_11_345_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591\u2010021\u201001678\u2010y"},{"key":"e_1_2_11_346_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.15025"},{"key":"e_1_2_11_347_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875\u2010020\u201000928\u2010x"},{"key":"e_1_2_11_348_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875\u2010021\u201001046\u2010y"},{"key":"e_1_2_11_349_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.03.091"},{"key":"e_1_2_11_350_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2022.06.009"},{"key":"e_1_2_11_351_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.08.016"},{"key":"e_1_2_11_352_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2022.01.001"},{"key":"e_1_2_11_353_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.04.002"},{"key":"e_1_2_11_354_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2021.07.021"},{"key":"e_1_2_11_355_1","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkab043"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.15552","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bcp.15552","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.15552","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T11:24:05Z","timestamp":1692444245000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.15552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,8]]},"references-count":354,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.1111\/bcp.15552"],"URL":"https:\/\/doi.org\/10.1111\/bcp.15552","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,8]]}}}